Intralytix Overview
- Year Founded
-
1998
- Status
-
Private
- Employees
-
36
- Latest Deal Type
-
Grant
- Financing Rounds
-
10
Intralytix General Information
Description
Operator of a biotechnology company intended to discover and produce bacteriophage-based products. The company's bacteriophage-based products controls bacterial pathogens in environmental, food processing and medical settings and kills targeted specific bacteria without affecting anything else, ensuring an unprecedented level of safety for an antimicrobial, enabling food, environmental sanitation, human therapeutics and technology companies to prevent listeriosis by killing strains of food-borne pathogenic bacteria.
Contact Information
Website
www.intralytix.comCorporate Office
- The Columbus Center
- 701 East Pratt Street
- Baltimore, MD 21202
- United States
Corporate Office
- The Columbus Center
- 701 East Pratt Street
- Baltimore, MD 21202
- United States
Intralytix Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Intralytix Comparisons
Industry
Financing
Details
Intralytix Competitors (2)
One of Intralytix’s 2 competitors is Armata Pharmaceuticals, a Formerly VC-backed company based in Los Angeles, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Armata Pharmaceuticals | Formerly VC-backed | Los Angeles, CA | ||||
| Merck & Co. | Corporation | Rahway, NJ |
Intralytix Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Intralytix Patents
Intralytix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240124851-A1 | Escherichia coli bacteriophages and uses thereof | Pending | 21-Sep-2022 | ||
| US-20220264896-A1 | Novel campylobacter bacteriophages and uses thereof | Pending | 21-Dec-2020 | ||
| CA-2974897-A1 | Novel shigella bacteriophages and uses thereof | Pending | 23-Jan-2015 | ||
| AU-2016209252-A1 | Novel shigella bacteriophages and uses thereof | Active | 23-Jan-2015 | ||
| AU-2016209252-B2 | Novel shigella bacteriophages and uses thereof | Active | 23-Jan-2015 | C12N7/00 |
Intralytix Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Intralytix Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Intralytix FAQs
-
When was Intralytix founded?
Intralytix was founded in 1998.
-
Where is Intralytix headquartered?
Intralytix is headquartered in Baltimore, MD.
-
What is the size of Intralytix?
Intralytix has 36 total employees.
-
What industry is Intralytix in?
Intralytix’s primary industry is Biotechnology.
-
Is Intralytix a private or public company?
Intralytix is a Private company.
-
What is Intralytix’s current revenue?
The current revenue for Intralytix is .
-
How much funding has Intralytix raised over time?
Intralytix has raised $19.6M.
-
Who are Intralytix’s investors?
United States Department of Agriculture, United States Department of Defense, and U.S. Department of Health and Human Services have invested in Intralytix.
-
Who are Intralytix’s competitors?
Armata Pharmaceuticals and Merck & Co. are competitors of Intralytix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
